BioCardia, Inc.
BCDA
$1.36
-$0.03-2.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -100.00% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -100.00% | -- |
| Cost of Revenue | 0.54% | 71.00% | 23.29% | -234.69% | -50.27% |
| Gross Profit | -0.54% | -71.64% | -29.01% | 236.22% | 38.55% |
| SG&A Expenses | -33.09% | -19.84% | 9.83% | -3.72% | -23.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.26% | 24.15% | 17.00% | 10.68% | -40.58% |
| Operating Income | 15.26% | -24.38% | -19.82% | -11.37% | 32.41% |
| Income Before Tax | 14.62% | -24.48% | -19.63% | -10.81% | 32.52% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.62% | -24.48% | -19.63% | -10.81% | 32.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.62% | -24.48% | -19.63% | -10.81% | 32.52% |
| EBIT | 15.26% | -24.38% | -19.82% | -11.37% | 32.41% |
| EBITDA | 14.71% | -25.37% | -20.30% | -11.72% | 32.48% |
| EPS Basic | 61.55% | 53.81% | 56.76% | 63.72% | 65.61% |
| Normalized Basic EPS | 61.56% | 53.82% | 56.76% | 63.72% | 65.60% |
| EPS Diluted | 61.55% | 53.81% | 56.76% | 27.27% | 65.61% |
| Normalized Diluted EPS | 61.56% | 53.82% | 56.76% | 63.72% | 65.60% |
| Average Basic Shares Outstanding | 122.03% | 169.55% | 176.68% | 205.47% | 96.22% |
| Average Diluted Shares Outstanding | 122.03% | 169.55% | 176.68% | 205.47% | 96.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |